Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.67 |
| ▸ | CNR1 | P21554 | 2/20 | 0.67 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.67 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | EPHX1 | P07099 | 6/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | NAAA | Q02083 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9620151 | 1.00 | LMNA (0.67) | LMNAKDM4ECNR1ADRA1ATDP1 | |
| SCHEMBL6249617 | 1.00 | LMNA (0.67) | LMNAKDM4ECNR1ADRA1ATDP1 | |
| SCHEMBL8975153 | 0.98 | LMNA (0.70) | LMNAKDM4ECNR1ADRA1ATDP1 | |
| SCHEMBL1222755 | 0.91 | LMNA (0.52) | LMNAKDM4ECNR1ADRA1ATDP1 | |
| SCHEMBL2346969 | 0.91 | LMNA (0.52) | LMNAKDM4ECNR1ADRA1ATDP1 | |
| SCHEMBL4781590 | 0.91 | LMNA (0.73) | LMNAKDM4ECNR1ADRA1ATDP1 | |
| SCHEMBL1223599 | 0.91 | LMNA (0.52) | LMNAKDM4ECNR1ADRA1ATDP1 | |
| SCHEMBL1222862 | 0.91 | LMNA (0.52) | LMNAKDM4ECNR1ADRA1ATDP1 | |
| SCHEMBL1219703 | 0.89 | LMNA (0.54) | LMNAKDM4ECNR1ADRA1ATDP1 | |
| Methyl Alcohol SCHEMBL28137239 | 0.86 | LMNA (0.52) | LMNAKDM4ECNR1ADRA1ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2860170-B1 | PROCESS FOR PREPARING 4-HYDROXYBUTYL ACRYLATE | OSAKA ORGANIC CHEMICAL IND LTD (JP) | 2019-08-28 | — | — | EP | disclosed |
| EP-3015449-B1 | (METH)ACRYLATE PRODUCTION SYSTEM | OSAKA ORGANIC CHEMICAL IND LTD (JP) | 2018-10-10 | — | — | EP | disclosed |
| US-9670129-B2 | Process for preparing 4-hydroxybutyl acrylate | OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (JP) | 2017-06-06 | — | — | US | disclosed |
| US-20160136538-A1 | (METH)ACRYLATE PRODUCTION SYSTEM | OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (JP) | 2016-05-19 | — | — | US | disclosed |
| EP-3015449-A1 | (METH)ACRYLATE PRODUCTION SYSTEM | Osaka Organic Chemical Ind., Ltd. (JP) | 2016-05-04 | — | — | EP | disclosed |
| US-20150126766-A1 | PROCESS FOR PREPARING 4-HYDROXYBUTYL ACRYLATE | OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (JP) | 2015-05-07 | — | — | US | disclosed |
| EP-2860170-A1 | PROCESS FOR PREPARING 4-HYDROXYBUTYL ACRYLATE | Osaka Organic Chemical Ind., Ltd. (JP) | 2015-04-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150126766-A1 | PROCESS FOR PREPARING 4-HYDROXYBUTYL ACRYLATE | LTB4R2, LTA4H, LTB4R | LMNA 1413/4885KDM4E 3193/4885CNR1 3836/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.